Diphenylamine assay of DNA fragmentation for chemosensitivity testing

Cicek Gercel-Taylor1

  • 1Department of Obstetrics and Gynecology and Women's Health, University of Louisville, KY, USA.

Insights

Quantifying apoptosis, or programmed cell death, helps understand cellular responses to chemotherapy. The diphenylamine assay is a simple, reproducible method for measuring DNA fragmentation during apoptosis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Apoptosis is a regulated cell death process triggered by various stimuli.
  • Chemotherapeutic agents can induce apoptosis, contributing to their efficacy.
  • Understanding apoptosis is crucial for studying cellular responses to cancer treatments.

Purpose of the Study:

  • To present the diphenylamine assay as a method for quantifying apoptosis.
  • To enable the study of differential cellular responses to chemotherapy.
  • To assess potential clinical sensitivity to chemotherapeutic agents.

Main Methods:

  • Utilized the diphenylamine assay to quantify DNA fragmentation, a hallmark of apoptosis.
  • Applied the assay to various cell cultures.
  • Employed a colorimetric reaction for quantitative analysis.

Main Results:

  • The diphenylamine assay effectively quantifies DNA degradation during apoptosis.
  • The protocol is simple and adaptable to different cell culture manipulations.
  • The assay demonstrated high reproducibility and ease of quantitation.

Conclusions:

  • The diphenylamine assay is a valuable tool for measuring apoptosis.
  • Quantifying apoptosis aids in understanding chemotherapy's effects on cells.
  • This method supports research into clinical sensitivity to cancer therapies.